Cargando…
Effects of Newer Antidiabetic Drugs on Endothelial Function and Arterial Stiffness: A Systematic Review and Meta-Analysis
BACKGROUND: Newer antidiabetic drugs, i.e., dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose cotransporter-2 (SGLT-2) inhibitors, and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may exert distinct cardiovascular effects. We sought to explore their impact on vascular function. METH...
Autores principales: | Batzias, Konstantinos, Antonopoulos, Alexios S., Oikonomou, Evangelos, Siasos, Gerasimos, Bletsa, Evanthia, Stampouloglou, Panagiota K., Mistakidi, Chara-Vasiliki, Noutsou, Marina, Katsiki, Niki, Karopoulos, Periklis, Charalambous, Georgios, Thanopoulou, Anastasia, Tentolouris, Nicholas, Tousoulis, Dimitris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304901/ https://www.ncbi.nlm.nih.gov/pubmed/30622967 http://dx.doi.org/10.1155/2018/1232583 |
Ejemplares similares
-
Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease
por: Mourouzis, Konstantinos, et al.
Publicado: (2021) -
The Anti-Inflammatory Effect of Novel Antidiabetic Agents
por: Theofilis, Panagiotis, et al.
Publicado: (2022) -
“Heart failure in COVID-19 patients: Critical care experience”: A letter to the editor
por: Tsigkou, Vasiliki, et al.
Publicado: (2022) -
Diabetes Mellitus in Acute Coronary Syndrome
por: Stampouloglou, Panagiota K., et al.
Publicado: (2023) -
Percutaneous Treatment Approaches in Atrial Fibrillation: Current Landscape and Future Perspectives
por: Theofilis, Panagiotis, et al.
Publicado: (2022)